Weight and weight change and risk of atrial fibrillation: the HUNT study
- PMID: 31209455
- DOI: 10.1093/eurheartj/ehz390
Weight and weight change and risk of atrial fibrillation: the HUNT study
Abstract
Aims: Although obesity has been associated with risk of atrial fibrillation (AF), the associations of long-term obesity, recent obesity, and weight change with AF risk throughout adulthood are uncertain.
Methods and results: An ambispective cohort study was conducted which included 15 214 individuals. The cohort was created from 2006 to 2008 (the baseline) and was followed for incident AF until 2015. Weight and height were directly measured at baseline. Data on previous weight and height were retrieved retrospectively from measurements conducted 10, 20, and 40 years prior to baseline. Average body mass index (BMI) over time and weight change was calculated. During follow-up, 1149 participants developed AF. The multivariable-adjusted hazard ratios were 1.2 (95% confidence interval 1.0-1.4) for average BMI 25.0-29.9 kg/m2 and 1.6 (1.2-2.0) for average BMI ≥30 kg/m2 when compared with normal weight. The association of average BMI with AF risk was only slightly attenuated after adjustment for most recent BMI. In contrast, current BMI was not strongly associated with the risk of AF after adjustment for average BMI earlier in life. Compared with stable BMI, both loss and gain in BMI were associated with increased AF risk. After adjustment for most recent BMI, the association of BMI gain with AF risk was largely unchanged, while the association of BMI loss with AF risk was weakened.
Conclusion: Long-term obesity and BMI change are associated with AF risk. Obesity earlier in life and weight gain over time exert cumulative effects on AF development even after accounting for most recent BMI.
Keywords: Atrial fibrillation; BMI; Weight; Weight change.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Comment in
-
No time to weight: obesity through life and AF risk.Eur Heart J. 2019 Sep 7;40(34):2867-2869. doi: 10.1093/eurheartj/ehz482. Eur Heart J. 2019. PMID: 31280285 No abstract available.
Similar articles
-
Adulthood weight changes, body mass index in youth, genetic susceptibility and risk of atrial fibrillation: a population-based cohort study.BMC Med. 2024 Aug 26;22(1):345. doi: 10.1186/s12916-024-03565-y. BMC Med. 2024. PMID: 39183287 Free PMC article.
-
Five-year changes in weight and risk of atrial fibrillation in the Danish Diet, Cancer, and Health Cohort.Eur J Prev Cardiol. 2024 Jan 25;31(2):244-249. doi: 10.1093/eurjpc/zwad300. Eur J Prev Cardiol. 2024. PMID: 37708406 Free PMC article.
-
Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation.Heart Rhythm. 2020 Mar;17(3):365-371. doi: 10.1016/j.hrthm.2019.09.029. Epub 2019 Oct 1. Heart Rhythm. 2020. PMID: 31585180
-
Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis.Heart. 2019 Dec;105(23):1799-1805. doi: 10.1136/heartjnl-2019-314931. Epub 2019 Jun 22. Heart. 2019. PMID: 31229991 Free PMC article.
-
Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis.J Cardiovasc Electrophysiol. 2018 May;29(5):725-732. doi: 10.1111/jce.13458. Epub 2018 Feb 27. J Cardiovasc Electrophysiol. 2018. PMID: 29443438 Review.
Cited by
-
Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome.Eur J Prev Cardiol. 2024 Mar 27;31(5):629-639. doi: 10.1093/eurjpc/zwad380. Eur J Prev Cardiol. 2024. PMID: 38102071 Free PMC article. Clinical Trial.
-
Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study.BMC Med. 2022 Sep 19;20(1):317. doi: 10.1186/s12916-022-02505-y. BMC Med. 2022. PMID: 36117169 Free PMC article.
-
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation.Cardiovasc Drugs Ther. 2021 Apr;35(2):261-272. doi: 10.1007/s10557-020-07126-2. Epub 2021 Jan 6. Cardiovasc Drugs Ther. 2021. PMID: 33404923 Free PMC article.
-
Transition of Metabolic Phenotypes and Risk of Atrial Fibrillation According to BMI: Kailuan Study.Front Cardiovasc Med. 2022 Jun 28;9:888062. doi: 10.3389/fcvm.2022.888062. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35837597 Free PMC article.
-
Association of long-term triglyceride-glucose index level and change with the risk of cardiometabolic diseases.Front Endocrinol (Lausanne). 2023 Mar 30;14:1148203. doi: 10.3389/fendo.2023.1148203. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37065738 Free PMC article.